Form 4: Alignment Healthcare CMO Sells Shares

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 16,506 shares of common stock under a pre-arranged 10b5-1 plan.

Summary

• Hyong Kim, Chief Medical Officer of Alignment Healthcare, Inc. (ALHC), reported a sale of common stock.
• The transaction involved the disposition of 16,506 shares of common stock.
• The shares were sold at a weighted-average price of $21.3472 per share.
• The per-share price for the sales ranged from $20.94 to $21.64.
• Following this transaction, Hyong Kim directly beneficially owns 333,133 shares of common stock.
• The sale was executed on January 6, 2026, pursuant to a Rule 10b5-1 plan adopted on March 14, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, but mitigated by the fact that the sale was pre-scheduled under a 10b5-1 plan, which suggests it's not based on new, adverse information.

Positives

• The transaction was executed pursuant to a Rule 10b5-1 plan adopted on March 14, 2025, indicating a pre-scheduled sale rather than a reaction to new, non-public information.

Negatives

• A high-ranking officer sold a significant number of shares (16,506 shares), reducing their direct beneficial ownership.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may perceive the sale by a Chief Medical Officer as a slight negative, although the pre-arranged nature of the 10b5-1 plan lessens the impact.

Key Dates

Recommendation

The sale of shares by a Chief Medical Officer, even if pre-scheduled under a 10b5-1 plan, represents a reduction in insider ownership. While not indicative of immediate negative news due to the plan's nature, it's a data point that warrants monitoring. Without additional company-specific or market-wide information, a 'hold' recommendation is appropriate as this single transaction does not fundamentally alter the investment thesis but adds a minor cautionary note.

Keywords

Alignment Healthcare, ALHC, Insider Sale, Form 4, Hyong Kim, Chief Medical Officer, Stock Transaction, 10b5-1 Plan